Bicocca Open Archive

Logo unimib boa
RE, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.733
EU - Europa 6.626
AS - Asia 3.106
SA - Sud America 216
AF - Africa 48
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 17
Totale 20.773
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.473
IT - Italia 2.013
DE - Germania 1.177
SG - Singapore 1.033
CN - Cina 938
SE - Svezia 729
IE - Irlanda 573
RU - Federazione Russa 531
HK - Hong Kong 361
UA - Ucraina 340
GB - Regno Unito 321
CA - Canada 239
FI - Finlandia 188
BR - Brasile 185
IN - India 171
ID - Indonesia 148
VN - Vietnam 144
AT - Austria 126
DK - Danimarca 114
FR - Francia 112
PL - Polonia 78
NL - Olanda 67
BE - Belgio 54
KR - Corea 51
IR - Iran 47
TR - Turchia 42
ES - Italia 35
JP - Giappone 33
PT - Portogallo 32
TW - Taiwan 32
RO - Romania 27
AU - Australia 24
BG - Bulgaria 22
GR - Grecia 20
CH - Svizzera 18
CZ - Repubblica Ceca 17
ZA - Sudafrica 17
EU - Europa 14
IL - Israele 14
PK - Pakistan 14
MX - Messico 11
MY - Malesia 10
IQ - Iraq 9
EG - Egitto 8
HU - Ungheria 8
UZ - Uzbekistan 8
BD - Bangladesh 7
PH - Filippine 7
VE - Venezuela 7
CL - Cile 6
LT - Lituania 6
AR - Argentina 5
MA - Marocco 5
MU - Mauritius 5
AZ - Azerbaigian 4
NO - Norvegia 4
PY - Paraguay 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CI - Costa d'Avorio 3
CO - Colombia 3
EC - Ecuador 3
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
NZ - Nuova Zelanda 3
PA - Panama 3
YE - Yemen 3
A2 - ???statistics.table.value.countryCode.A2??? 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
JM - Giamaica 2
LU - Lussemburgo 2
LV - Lettonia 2
NG - Nigeria 2
OM - Oman 2
PE - Perù 2
QA - Qatar 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HR - Croazia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
SC - Seychelles 1
Totale 20.772
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.788
Woodbridge 866
Milan 799
Singapore 687
Frankfurt am Main 686
Fairfield 670
Chandler 632
Wilmington 564
Houston 556
Dublin 552
Ashburn 526
Dearborn 370
Jacksonville 352
Hong Kong 337
Seattle 311
Santa Clara 295
Cambridge 242
New York 217
Princeton 191
Nanjing 161
Jakarta 140
Shanghai 115
Vienna 110
Helsinki 106
Beijing 92
Kraków 74
Toronto 74
Lawrence 72
Guangzhou 71
San Diego 63
Altamura 62
Dong Ket 62
Ottawa 59
Lachine 58
Nanchang 54
Council Bluffs 53
Fremont 52
Brussels 50
Melzo 46
Rome 43
Wayne 43
Moscow 40
Boardman 35
Kunming 35
Los Angeles 34
Monza 34
Andover 33
Pune 33
Hangzhou 32
Hebei 30
Shenyang 30
Changsha 27
Chicago 27
Nürnberg 26
Grafing 25
Norwalk 24
Nuremberg 24
Zhengzhou 24
Como 23
Tianjin 23
São Paulo 22
Dallas 21
Falls Church 21
Genoa 21
Plovdiv 21
Jiaxing 20
Jinan 20
Lecco 20
London 20
Munich 20
Carate Brianza 19
Bergamo 18
Brescia 18
Florence 18
Turin 18
Edmonton 16
Lansing 16
Segrate 14
Washington 14
Mountain View 13
New Delhi 13
Taipei 13
Taizhou 13
Copenhagen 12
Huizen 12
Kiev 12
Palermo 12
Sacramento 12
Auburn Hills 11
Bologna 11
Boston 11
Ningbo 11
Redmond 11
San Mateo 11
Verona 11
Ahmedabad 10
Cesena 10
Cinisello Balsamo 10
Hefei 10
Montréal 10
Totale 14.456
Salva come PNG Salva come JPEG
Nome #
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 507
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 502
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 408
A new approach for glyco-functionalization of collagen-based biomaterials 394
Differential Exchange of Multifunctional Liposomes Between Glioblastoma Cells and Healthy Astrocytes via Tunneling Nanotubes 392
The clustering of mapoe anti-amyloidogenic peptide on nanoparticle surface does not alter its performance in controlling beta-amyloid aggregation 386
Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size- and time-dependent manner 385
Coupling quaternary ammonium surfactants to the surface of liposomes improves both antibacterial efficacy and host cell biocompatibility 375
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 355
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 340
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 337
Phage-displayed peptides targeting specific tissues and organs 335
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 330
The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro 312
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 304
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 289
Nanomedicine for the treatment of Alzheimer's disease 278
Multifunctional Liposomes Modulate Purinergic Receptor-Induced Calcium Wave in Cerebral Microvascular Endothelial Cells and Astrocytes: New Insights for Alzheimer’s disease 269
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 266
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 259
Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes 259
Enhanced brain targeting of engineered solid lipid nanoparticles 256
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 256
Oxidative stress boosts the uptake of cerium oxide nanoparticles by changing brain endothelium microvilli pattern 256
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 251
Are the nanoparticles friends or foes when inhaled? 249
The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB 249
TrkA pathway activation induced by amyloid-beta (Abeta) 246
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 240
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease 239
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 239
Tat-1-liposomes to overcome the blood-brain barrier: an in vitro study 232
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 226
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 216
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 216
Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 212
Effect of modified collagen on amyloid beta peptide aggregation 210
An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy 209
Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model 208
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 208
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 205
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 205
Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice 204
Preparation and characterization of lipid-based nanoparticles binding with high affinity amyloid-beta(1-42) peptide 201
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 200
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 200
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 198
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 192
Nanoparticles at the neurovascular unit: In vitro and in vivo studies to assess the blood-brain barrier permeability and function 190
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 182
Enhanced brain targeting of engineered solid lipid nanoparticles 181
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 180
Reduced levels of ABCA1 transporter are responsible for the cholesterol efflux impairment in β‐amyloid‐induced reactive astrocytes: Potential rescue from biomimetic HDLs 179
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 178
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 178
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 174
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 173
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 169
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 168
Molecular dynamics simulations of doxorubicin in sphingomyelin-based lipid membranes 168
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 166
Nanotechnology for neurodegenerative disorders 166
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 165
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 165
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 161
Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells actively induced by brain targeted liposomes 159
Nanotechnology for neurodegenerative disorders 156
Effect of curcumin-associated and lipid ligand functionalised nanoliposomes on aggregation of the Alzheimer's Aβ peptide 153
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 151
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 150
Applications of Surface Plasmon Resonance (SPR) for the Characterization of Nanoparticles Developed for Biomedical Purposes 149
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 149
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 148
Development of a 3D in vitro model mimicking the changes occurring at the blood-brain barrier during Alzheimer’s disease 148
Pulmonary administration of functionalized nanoparticles significantly reduces beta-amyloid in the brain of an Alzheimer’s disease murine model 141
Design and validation of a microfluidic device for blood-brain barrier monitoring and transport studies 141
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model 141
Self-assembled electrical biodetector based on reduced graphene oxide 140
The 3.0 cell communication: New insights in the usefulness of tunneling nanotubes for glioblastoma treatment 140
Liposomes capable of effectively binding the beta-amyloid peptide 138
The interaction of complement system with abeta-binding liposomes: towards engineering of safer vesicles for the management of alzheimer's disease 138
Liposomes functionalized with GT1b ganglioside with high affinity for amyloid beta-peptide 138
From the lungs to the brain: the fantastic voyage of nanoparticles targeting beta-amyloid 135
Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence 134
Nanoparticles for neuroimaging 131
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 130
Amyposomes: a new nanomedicine for therapy of Alzheimer disease, waiting for clinical trials 126
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 124
Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model 121
Potential nanotherapeutic approach for Alzheimer's disease: in vitro clearance of beta-amyloid across the blood-brain barrier by multifunctional liposomes 118
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 117
Nanoparticles modulate the stability of the nuclear structure interfering in the mechanical connection between plasma membrane and nucleus 109
Design of nanoparticles for the treatment of brain tumors 109
Liposomes containing acid lipids and functionalized with a peptide eliciting an efficient removal of beta-amyloid peptide burden from the brain of animal models (transgenic mice) of Alzheimer disease. 101
Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells actively induced by brain targeted liposomes 97
The fantastic voyage of solid lipid nanoparticles from the lung to the brain: non‐invasive tomographic imaging as a feasible refinement process 92
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 88
Direct and indirect air pollution effects on synaptic neurotransmission linked to the development of neurodegenerative disease 87
In Vitro Biocompatibility and Endothelial Permeability of Branched Polyglycidols Generated by Ring-Opening Polymerization of Glycidol with B(C6F5)3 under Dry and Wet Conditions 85
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 82
Totale 20.714
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.085
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.085
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020528 0 0 0 0 0 0 0 0 0 232 217 79
2020/20213.055 161 139 306 277 222 277 284 275 278 299 215 322
2021/20222.187 200 204 198 209 148 188 164 136 114 164 181 281
2022/20232.938 359 818 293 295 198 432 57 140 166 33 86 61
2023/20242.332 64 81 132 161 240 542 410 117 134 55 114 282
2024/20253.675 280 461 393 305 456 370 387 224 618 181 0 0
Totale 21.671